Skip to main content
v2026.11,986 entries · CC-BY 4.0
LAC HealthSponsored

Shop medical supplies

  • FDA registered
  • ISO 13485
  • BBB Accredited A+

Shop at LAC Health

Editorial · CASRAI · Research integrity and misconduct

Lancet Retracts 2006 Koren Codeine Breastfeeding Case Report After SickKids Finds Falsification

The Lancet retracted a 2006 codeine and breastfeeding case report after SickKids found omitted toxicology data amounted to falsification.

Published 21 Nov 2026· 6 minute read
Display shelves of printed scientific journals in a university library reading area
Photo: Vmenkov / Wikimedia Commons, CC BY-SA 3.0 (cropped). Source · Licence

The Lancet has retracted a 2006 case report that attributed an Ontario infant’s death to morphine passed through breast milk, after a Hospital for Sick Children (SickKids) inquiry concluded that omitting toxicology data from the paper amounted to falsification. Retraction Watch reported the retraction on November 20, 2026, and CBC News followed on November 21, the date of the issue carrying the notice.

What happened

The retracted paper, “Pharmacogenetics of morphine poisoning in a breastfed neonate of a codeine-prescribed mother”, appeared in The Lancet in August 2006. It described the death of a baby boy whose mother had been prescribed Tylenol with codeine, an opioid that the body partly metabolises into morphine. Its first author, pharmacologist Gideon Koren of SickKids, used the case for years to argue that codeine taken by a breastfeeding mother can pose a lethal risk to her infant, according to Retraction Watch.

The route to retraction began in January 2026. A New Yorker article renewed attention on the case, and a former PhD student of Koren’s came forward with new allegations. A Lancet spokesperson told Retraction Watch that on January 20, 2026 the journal was contacted with new allegations that important toxicology data were left out of the paper. The journal added an expression of concern in February and referred the allegations to SickKids, CBC reported.

SickKids’ research integrity office then reported its conclusions to the journal. The retraction notice, as quoted by CBC, says: “On the allegation of omission of material toxicological data, including the infant’s blood codeine and acetaminophen concentrations and the qualitative identification of codeine in the infant’s stomach contents, the report concluded that this omission constitutes falsification. The omitted findings left readers without the information necessary to assess the publication’s conclusion.”

Key details

  • The finding: SickKids told CBC that its formal inquiry determined the omission “constituted falsification under SickKids’ Responsible Conduct of Research Policy”.
  • What was omitted: the infant’s blood concentrations of codeine and acetaminophen, and the identification of codeine in the infant’s stomach contents.
  • What the inquiry could not examine: the notice states that authorship issues and ethical concerns “could not be fairly investigated as a meaningful participation of Gideon Koren was unlikely to be possible”.
  • Reach of the paper: Retraction Watch cites Clarivate’s Web of Science for 464 citations to the case report.
  • Guidance link: Retraction Watch notes that a 2017 U.S. Food and Drug Administration drug safety communication recommending against prescribing codeine for pain in breastfeeding women cited 19 papers, seven of them with Koren as an author, including the retracted report.

Background and context

Koren left SickKids in 2015 after an investigation into Motherisk, a laboratory he founded that tested for perinatal exposure to drugs and alcohol, including for criminal and child protection cases. Retraction Watch reports that the investigation, prompted by Toronto Star coverage, found the laboratory’s test results “inadequate and unreliable”, and that more than 400 of his papers came under scrutiny by the hospital. CBC adds that the facility closed in 2019 and that Koren relinquished his medical licence in Ontario.

The codeine case had been challenged before. Retraction Watch counts six earlier retractions for Koren, two of them papers on the safety of codeine during breastfeeding. Two Canadian journals retracted articles on the same case after consulting external experts, citing “clear evidence that the findings are unreliable”. In 2020, pharmacologists David Juurlink and Jonathan Zipursky published a review concluding that morphine toxicity through breast milk was unlikely; they calculated that the morphine concentration in a breast milk sample from the mother was relatively small and that the baby’s blood codeine concentration was 100 times higher than would be expected from breast milk.

The New Yorker article also discussed a second case report, “Baby boy blue”, in Paediatrics and Child Health. Following inquiries, that journal issued a correction to the report and 137 other case reports to denote that they were fictionalized, according to Retraction Watch.

Reaction

Juurlink, a Toronto internist and pharmacologist at the University of Toronto, told CBC that the paper “is the cornerstone of an entire field of pediatric pharmacology and toxicology that, honestly, should not exist”. He also said the idea that babies can die from opioids passed through breast milk “has greatly influenced postpartum pain care” and “has caused women taking opioids to forgo breastfeeding”. He called the notice “a long time coming” and said it took investigative journalism to expose the institutional failures that kept the paper alive for 20 years.

Juurlink told Retraction Watch the report was “the foundational document in an entire branch of pediatric pharmacology that’s just been made up out of whole cloth”, adding that had the codeine and acetaminophen levels been published, “it would have been obvious from day one that the interpretation was wrong”. A SickKids spokesperson told CBC that the hospital “takes all matters of research integrity seriously”.

What it means for researchers, universities and research offices

For authors and reviewers, the case is a concrete example of how a falsification finding can rest on omission rather than invention: the notice treats leaving out material toxicology results as falsification because readers could not assess the conclusion. Anyone who cites the 2006 report should check their reference lists against the retraction; the guide on citing a retracted paper explains what to do with a citation that has been retracted.

For research integrity offices, the sequence shows the division of labour between journals and institutions. The Lancet issued an expression of concern, referred the allegations to the hospital where the work was done, and relied on that inquiry’s written conclusion before issuing the retraction. The notice also records that authorship and ethical questions went unexamined because the respondent’s participation was unlikely, a reminder that an inquiry’s reach depends on who takes part. Offices designing procedures can compare this with the stages described in how a research misconduct investigation works.

For universities and funders, the case also illustrates a point Juurlink raised: that a single paper can stay in the literature for two decades before it is withdrawn. Retraction Watch’s citation count and its note on the 2017 FDA communication show how widely one report was cited.

What happens next

The retraction notice appears in The Lancet’s issue dated November 21, 2026. SickKids said it would not provide further details of its findings because of the confidential nature of research integrity inquiries, so the full inquiry report is not public.

Sources

Ask CASRAI · full access

Ask about this story

Full access: large monthly usage, up to 10 source passages behind each answer, and MCP and API access for Claude Code, Codex and other CLIs. Cancel any time.

An AI assistant for research: funder rules, compliance, methods and publishing. It links the sources behind its answers and labels answers that come from a web search.

Answers draw on CASRAI's guides and dictionary plus the federal and funder documents we index: Federal Register, Grants.gov, Regulations.gov and UKRI.

Works on this site and inside Claude, Cursor and the AI tools you already use.

Everything CASRAI publishes — this page, the dictionary, the guides and the news — stays open to read, with no account and no card.

Referenced across the research world

University of Cambridge logoColumbia University logoCrossref logoUniversity of Edinburgh logoHarvard University logoUniversity of Oxford logoPrinceton University logoStanford School of Medicine logoUniversity College London logoORCID logoUniversity of Cambridge logoColumbia University logoCrossref logoUniversity of Edinburgh logoHarvard University logoUniversity of Oxford logoPrinceton University logoStanford School of Medicine logoUniversity College London logoORCID logo
  • University of Cambridge logo
  • Columbia University logo
  • Crossref logo
  • University of Edinburgh logo
  • Harvard University logo
  • University of Oxford logo
  • Princeton University logo
  • Stanford School of Medicine logo
  • University College London logo
  • ORCID logo

View CASRAI adoption →